Medicine for treating hyperosteogeny

Abstract

The invention relates to a medicine for curing osteoproliferation, prepared of the following raw materials in weight shares: Impatiens balsamina L 75-95, Ground Beetle 30-52, Rhizoma Cibotii 25-47, saltpeter 30-50, Dragon's blood 25-45, Radix Dipsaci 25-47, Pangolin Scales 20-40, Clematis Root 60-80, Garden Balsam Stem 25-47, Baihuashe 20-40, Nanxing prepared with ginger-alum 30-50, Common Floweringquince Fruit 30-50, Centipede 20-40, White Mustard Seed 16- 28, and Radix Puerariae 30-50 by crushing and uniformly mixing, where Garden Balsam Stem is ground leaf, Nanxing prepared with Jiangfan is prepared by using ginger-alum juice to soak raw Nanxing pieces in the weight ratio of Fresh Ginger juice to alum to Nanxing pieces 5 to 0.03 to 1, using new ginge-alum juice to continue soaking every two days and nights until seven times and then taking out the soaked Nanxing pieces; and it has characters of integrating functions of softening hard and removing bone, breaking accumulation and dispelling blood stasis, and dredging meridian and removing rheumatism; being uneasy to damage the spleen and stomach; and high cure rate.

Description

technical field [0001] The invention relates to a medicine for treating hyperosteogeny, in particular to a Chinese patent medicine made from Chinese herbal medicines. Background technique [0002] Osteoarthritis belongs to the category of bone paralysis in traditional Chinese medicine, which includes the degenerative changes of bones known in modern medicine; hyperosteogeny has different pathogenesis from rheumatism and rheumatoid disease, but the existing traditional Chinese medicine for treating hyperosteogeny, For example, Guci Tablets are collectively said to treat rheumatism and rheumatoid disease, and their prescriptions are mostly used to treat wind. For example, there are few medicines for softening and hardening bone and treating hyperplasia; from this point of view, it is okay to treat rheumatism diseases, but it is more difficult to treat hyperosteogeny diseases, and its cure rate for hyperosteogeny is In addition, the existing traditional Chinese medicine for th...

AI Technical Summary

Problems solved by technology

[0002] Osteoarthritis belongs to the category of bone paralysis in traditional Chinese medicine, which includes the degenerative changes of bones known in modern medicine; hyperosteogeny has different pathogenesis from rheumatism and rheumatoid disease, but the existing traditional Chinese medicine for treating hyperosteogeny, For example, Guci Tablets are collectively said to treat rheumatism and rheumatoid disease, and the research on its prescriptions is more about treating wind, such as dispelling wind, eliminating dampness, relieving pain, and dispelling rheumatism, nourishing liver and kidney, strengthening muscles and bones, dispelling blood stasis and relieving pain, less For example, there are few medicines for softening and softening bone and treating hyperplasia; from this point of view, it is okay to treat rheumatism diseases, but it is more difficult to treat hyperosteogeny diseases, and its cure rate for hyperosteogeny is In addition, the existing traditional Chinese medicine for the treatment of hyperosteogeny, because of its warm and hot nature, takes a little longer, which will cause fever in the stomach, pantothenic acid, fullness, loss of appetite, and even stomach pain and other symptoms that hurt the spleen and stomach. Phenomena appear